Cargando…
Lipoxin A4 improves erectile dysfunction in rats with type I diabetes by inhibiting oxidative stress and corporal fibrosis
Previous studies have shown that oxidative stress and corporal fibrosis in penile tissues of rats were key pathological factors of erectile dysfunction induced by diabetic mellitus (DMED). Lipoxin A4 (LXA4) was reported to inhibit oxidative stress and fibrosis diseases, while whether it could exert...
Autores principales: | Cui, Kai, Tang, Zhe, Li, Chuan-Chang, Wang, Tao, Rao, Ke, Wang, Shao-Gang, Liu, Ji-Hong, Chen, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858102/ https://www.ncbi.nlm.nih.gov/pubmed/29111541 http://dx.doi.org/10.4103/aja.aja_49_17 |
Ejemplares similares
-
AB088. FTY720 supplementation partially improves erectile dysfunction in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and corporal fibrosis
por: Cui, Kai, et al.
Publicado: (2017) -
Reduced corporal fibrosis to protect erectile function by inhibiting the Rho-kinase/LIM-kinase/cofilin pathway in the aged transgenic rat harboring human tissue kallikrein 1
por: Cui, Kai, et al.
Publicado: (2017) -
Human tissue kallikrein-1 protects against the development of erectile dysfunction in a rat model of hyperhomocysteinemia
por: Cui, Kai, et al.
Publicado: (2019) -
Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010) -
AB228. Research on the mechanism of androgen replacement therapy improving erectile dysfunction in castrated rats
por: Cui, Kai, et al.
Publicado: (2016)